Cardiovascular devices often approved by FDA without high-quality studies, study suggests

Pre-market approval by the FDA of cardiovascular devices is often based on studies that lack adequate strength or may have been prone to bias, according to a new study. Researchers found that of nearly 80 high-risk devices, the majority received approval based on data from a single study.

Read the whole article on Science Daily

More from Science Daily